AMERIFLEX GROUP, INC.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2057637
LAS VEGAS, NV
Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,727
+$191 QoQ
Shares Held
51
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#632
of 671 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIFLEX GROUP, INC. holds $23,830 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
468 | $7,431 | |
| 2 | ZTS |
Zoetis Inc.
|
82 | $5,892 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
123 | $3,027 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
51 | $1,727 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
106 | $1,699 | |
| 6 | HLN |
Haleon plc
|
161 | $1,502 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2 | $1,083 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
16 | $744 |
All Filings in TEVA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,727 | 51 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,536 | 51 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,591 | 51 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,060 | 102 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,329 | 318 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $783 | 51 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,124 | 51 | Shares | Sole | 2025-02-24 | |
| No filing history on record for this holder in this stock. | ||||||